CACIA WILSON: Open Payments
NPI 1619362076 · LAFAYETTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 27 payments from 8 companies in 2025. Trend: 2023 $624 · 2024 $356 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $259 |
| Lilly USA, LLC | 1 | $96 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $86 |
| Abbott Laboratories | 3 | $58 |
| Exact Sciences Corporation | 3 | $51 |
| Medtronic, Inc. | 1 | $21 |
| Dexcom, Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: Ozempic, MOUNJARO, CAPLYTA, FREESTYLE LIBRE 3, Cologuard Collection Kit, INTELLIS ADAPTIVESTIM, Rybelsus, Dexcom G6 Transmitter.
Industry payments across IN — which companies pay providers there.
